Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. DORM
DORM logo

DORM Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Dorman Products Inc (DORM) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
109.920
1 Day change
-1.49%
52 Week Range
166.890
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Dorman Products Inc (DORM) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock shows mixed signals with limited positive catalysts, and recent financial performance raises concerns. While analysts have upgraded the stock and see long-term growth potential, the lack of significant trading trends, weak recent financials, and neutral technical indicators suggest holding off on immediate investment.

Technical Analysis

The MACD is positive but contracting, RSI is neutral at 46.739, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level of 105.319, with resistance at 109.705 and support at 100.934.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
8
Buy
6

Positive Catalysts

  • Analysts see long-term growth potential and have upgraded the stock, citing record margins and strong cash generation. Light Duty demand remains robust, and Heavy Duty demand shows signs of recovery.

Neutral/Negative Catalysts

  • Q4 2025 financials show a significant drop in net income (-78.79% YoY) and EPS (-78.53% YoY). The stock has underperformed recently, and there are no significant trading trends or recent news to drive momentum.

Financial Performance

In Q4 2025, revenue increased slightly by 0.78% YoY, but net income and EPS dropped significantly by -78.79% and -78.53% YoY, respectively. Gross margin improved by 2.53% YoY to 42.59%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have mixed views. Roth Capital lowered the price target to $162 but maintains a Buy rating. Jefferies upgraded the stock to Buy with a reduced price target of $140, citing attractive valuation despite weak Q1 guidance. Barrington lowered the price target to $150, citing tariff-related noise in 2025 results.

Wall Street analysts forecast DORM stock price to rise
2 Analyst Rating
Wall Street analysts forecast DORM stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 111.580
sliders
Low
150
Averages
165
High
180
Current: 111.580
sliders
Low
150
Averages
165
High
180
Roth Capital
Buy
downgrade
$182 -> $162
AI Analysis
2026-03-02
Reason
Roth Capital
Price Target
$182 -> $162
AI Analysis
2026-03-02
downgrade
Buy
Reason
Roth Capital lowered the firm's price target on Dorman Products to $162 from $182 and keeps a Buy rating on the shares. The company reported better than expected Q4 results but lower than expected FY26 guidance, the analyst tells investors in a research note. Light Duty demand continues to be robust, while Heavy Duty seems to have turned the corner and Specialty remains steady, the firm added.
Jefferies
Hold
to
Buy
upgrade
$159 -> $140
2026-03-02
Reason
Jefferies
Price Target
$159 -> $140
2026-03-02
upgrade
Hold
to
Buy
Reason
Jefferies upgraded Dorman Products to Buy from Hold with a price target of $140, down from $159. The firm believes the stock's recent underperformance has created an attractive entry point. The shares are trading at an historical discount after the "downbeat" Q1 guidance, despite it posting recent record margins, strong cash generation, and "clear" long-term growth visibility, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for DORM
Unlock Now

People Also Watch